VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,678,000 | -28.2% | 61,278 | +0.6% | 0.27% | -15.3% |
| Q1 2022 | $2,336,000 | -1.8% | 60,903 | -18.0% | 0.31% | +4.3% |
| Q4 2021 | $2,378,000 | +8.4% | 74,239 | -0.3% | 0.30% | +2.0% |
| Q3 2021 | $2,194,000 | -13.5% | 74,457 | -0.3% | 0.30% | -13.0% |
| Q2 2021 | $2,537,000 | +3.3% | 74,673 | -1.2% | 0.34% | -2.3% |
| Q1 2021 | $2,456,000 | -49.6% | 75,566 | -44.1% | 0.35% | -53.7% |
| Q4 2020 | $4,872,000 | -6.4% | 135,258 | +1.8% | 0.75% | -20.8% |
| Q3 2020 | $5,204,000 | +7.7% | 132,890 | +0.8% | 0.95% | -1.9% |
| Q2 2020 | $4,833,000 | +114.3% | 131,771 | +34.6% | 0.96% | +78.8% |
| Q1 2020 | $2,255,000 | -23.2% | 97,891 | -2.4% | 0.54% | -4.9% |
| Q4 2019 | $2,935,000 | +8.8% | 100,252 | -0.7% | 0.57% | -0.5% |
| Q3 2019 | $2,697,000 | +917.7% | 100,987 | +907.1% | 0.57% | +738.2% |
| Q3 2016 | $265,000 | – | 10,028 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |